<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Stent maker CardioMind raises $33M</title>
	<atom:link href="http://venturebeat.com/2007/07/03/stent-maker-cardiomind-raises-33m/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/07/03/stent-maker-cardiomind-raises-33m/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Wed, 25 Nov 2009 02:43:52 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Stent maker CardioMind starts trial, gets $22M &#187; VentureBeat</title>
		<link>http://venturebeat.com/2007/07/03/stent-maker-cardiomind-raises-33m/comment-page-1/#comment-800990</link>
		<dc:creator>Stent maker CardioMind starts trial, gets $22M &#187; VentureBeat</dc:creator>
		<pubDate>Mon, 31 Mar 2008 20:33:01 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/07/03/stent-maker-cardiomind-raises-33m/#comment-800990</guid>
		<description>[...] CardioMind, a Sunnyvale, Calif., developer of artery-opening stents, said it launched the first human tests of its experimental product. That milestone triggered the release of $22 million &#8212; a second tranche of a $33 million funding the company initially reported last July. [...]</description>
		<content:encoded><![CDATA[<p>[...] CardioMind, a Sunnyvale, Calif., developer of artery-opening stents, said it launched the first human tests of its experimental product. That milestone triggered the release of $22 million &#8212; a second tranche of a $33 million funding the company initially reported last July. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; The storm over stents hits venture firms, as Devax yanks $85M IPO filing</title>
		<link>http://venturebeat.com/2007/07/03/stent-maker-cardiomind-raises-33m/comment-page-1/#comment-679800</link>
		<dc:creator>VentureBeat &#187; The storm over stents hits venture firms, as Devax yanks $85M IPO filing</dc:creator>
		<pubDate>Fri, 14 Dec 2007 23:06:52 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/07/03/stent-maker-cardiomind-raises-33m/#comment-679800</guid>
		<description>[...] That&#8217;s particularly bad news for venture-backed stent makers, which had seemed to ride out the storm over stent safety fairly well over the past year. In February, for instance, XTent raised $76 million in an IPO, while in July CardioMind pulled in $33 million in a third venture round (our coverage here and here). [...]</description>
		<content:encoded><![CDATA[<p>[...] That&#8217;s particularly bad news for venture-backed stent makers, which had seemed to ride out the storm over stent safety fairly well over the past year. In February, for instance, XTent raised $76 million in an IPO, while in July CardioMind pulled in $33 million in a third venture round (our coverage here and here). [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
